DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study

<h4>Background</h4> <p>Leucine-rich repeat kinase 2 (LRRK2) mutation 6055G→A (Gly2019Ser) accounts for roughly 1% of patients with Parkinson’s disease in white populations, 13–30% in Ashkenazi Jewish populations, and 30–40% in North African Arab-Berber populations, although age of...

Full description

Bibliographic Details
Main Authors:	Parkkinen, L, Trinh, J, Gustavsson, E, Vilariño-Güell, C, Bortnick, S, Latourelle, J, McKenzie, M, Tu, C, Nosova, E, Khinda, J, Milnerwood, A, Lesage, S, Brice, A, Tazir, M, Aasly, J, Haytural, H, Foroud, T, Myers, R, Ben Sassi, S, Hentati, E, Nabli, F, Farhat, E, Amouri, R, Hentati, F, Farrer, M
Format:	Journal article
Published:	Elsevier 2016

DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study

Similar Items